IMRN

$0.00

(

0.00%

)
Quote details

stock

Immuron Ltd ADR

NASDAQ | IMRN

1.81

USD

0.00

(

0.00%

)

AT CLOSE (AS OF Aug 15, 2025)

$10M

MARKET CAP

-

P/E Ratio

-0.84

EPS

$2.9

52 Week High

$1.5

52 Week Low

LIFE SCIENCES

Sector

IMRN Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

IMRN Technicals

Tags:

IMRN Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $3.3M
Total Revenue $4.9M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$5.8M
Selling General And Administrative $4.5M
Research And Development $5.4M
Operating Expenses $9.1M
Investment Income Net -
Net Interest Income $320K
Interest Income $328K
Interest Expense $7.6K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $46K
Income Before Tax -$6.9M
Income Tax Expense -$765K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.9M
Comprehensive Income Net Of Tax -
Ebit -$6.9M
Ebitda -$6.9M
Net Income -$6.9M

Revenue & Profitability

Earnings Performance

IMRN Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (AUD)
Total Assets $16M
Total Current Assets $15M
Cash And Cash Equivalents At Carrying Value $12M
Cash And Short Term Investments $12M
Inventory $1.6M
Current Net Receivables $1.4M
Total Non Current Assets $824K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $0
Other Current Assets $97K
Other Non Current Assets -
Total Liabilities $2.8M
Total Current Liabilities $2.7M
Current Accounts Payable $649K
Deferred Revenue -
Current Debt -
Short Term Debt $41K
Total Non Current Liabilities $142K
Capital Lease Obligations $173K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $173K
Other Current Liabilities $2M
Other Non Current Liabilities -
Total Shareholder Equity $13M
Treasury Stock -
Retained Earnings -$79M
Common Stock $89M
Common Stock Shares Outstanding $5.7M

yearly Cash Flow (As of Jun 30, 2024)

Field Value (AUD)
Operating Cashflow -$5.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $195
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $328K
Cashflow From Financing $829
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$6.9M

yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $3.3M
Total Revenue $4.9M
Cost Of Revenue $1.6M
Costof Goods And Services Sold $1.6M
Operating Income -$5.8M
Selling General And Administrative $4.5M
Research And Development $5.4M
Operating Expenses $9.1M
Investment Income Net -
Net Interest Income $320K
Interest Income $328K
Interest Expense $7.6K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $46K
Income Before Tax -$6.9M
Income Tax Expense -$765K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.9M
Comprehensive Income Net Of Tax -
Ebit -$6.9M
Ebitda -$6.9M
Net Income -$6.9M

IMRN News

IMRN Profile

Immuron Ltd ADR Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immunomodulated diseases in Australia, the United States and internationally. The company is headquartered in Carlton, Australia.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.